Michael Gutmann

3PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 07, 2025
Albumin-targeted oxaliplatin(iv) prodrugs bearing STING agonists.

Martijn Dijkstra, Michael Gutmann, Mathias Gradl

|Jan 25, 2023
A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance.

Philipp Fronik, Michael Gutmann, Petra Vician

|May 28, 2021
Development of a cobalt(iii)-based ponatinib prodrug system.

Marlene Mathuber, Michael Gutmann, Mery La Franca

Pageof 1